Get the latest Science News and Discoveries

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Related news:

Common Constipation Drug Shows Promise in Halting Kidney Decline

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors - EurekAlert!

First-ever clinical trial demonstrates safety, molecular readout and promise of pre- and post-surgery immunotherapy combination for patients with operable mesothelioma - EurekAlert!

« Well-publicized polar geoengineering ideas will not help and could harm, warn experts - EurekAlert!

First-ever complete measurement of a black-hole recoil achieved thanks to gravitational waves »